FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383873973> ?p ?o ?g. }

• W4383873973 endingPage "103991" @default.
• W4383873973 startingPage "103991" @default.
• W4383873973 abstract "MPOX has numerous otolaryngologic presentations that have been recognized as clinically important, especially with the onset of the 2022 outbreak. However, how these features vary across region and outbreak have yet to be elucidated or supported by meta-analysis. The objective of this study is to identify the otolaryngologic manifestations of MPOX across previous and current outbreaks and among endemic and non-endemic regions. Data sources of MEDLINE (PubMed), the Cochrane Library, Scopus, Embase, Web of Science, Google Scholar, and OpenGrey were searched through August 2022. All observational studies reporting data on laboratory-confirmed MPOX patients with otolaryngologic symptoms were included. Two authors independently performed the screening process while a third resolved disagreements. Data were extracted into a structured form by two authors independently. We performed a meta-analysis of the prevalence of otorhinolaryngologic symptoms using MetaXL software (version 5.3) under a random-effects model. 38 studies with 5952 patients were included. The four most prevalent manifestations were headache at 31 % (95 % CI [0.16–0.49], I2 = 99 %), sore throat at 22 % (95 % CI [0.09–0.37], I2 = 99 %), cough at 16 % (95 % CI [0.05–0.30], I2 = 99 %), and cervical lymphadenopathy at 10 % (95 % CI [0.01–0.26], I2 = 100 %). Otolaryngologic features were more prevalent in previous outbreaks as compared to the 2022 outbreak including 37 % prevalence of headache (95 % CI [0.11–0.66], I2 = 100 %), 33 % prevalence of cough (95 % CI [0.21–0.47], I2 = 98 %), 27 % prevalence of sore throat (95 % CI [0.07–0.53], I2 = 99 %), 15 % prevalence of cervical lymphadenopathy (95 % CI [0.00–0.428], I2 = 100 %), 13 % prevalence of oral ulcers (95 % CI [0.02–0.30], I2 = 99 %), 6 % prevalence of oral exanthem (95 % CI [0.00–0.17], I2 = 99 %), 5 % prevalence of dysphagia (95 % CI [0.00–0.18], I2 = 99 %), and 5 % prevalence of tonsillar signs (95 % CI [0.00–0.13], I2 = 99 %). Features that were more prevalent in endemic areas versus non-endemic areas include 27 % prevalence of cough (95 % CI [0.14–0.41], I2 = 99 %), 15 % prevalence of oral ulcers (95 % CI [0.02–0.36], I2 = 99 %), 6 % prevalence of tonsillar signs (95 % CI [0.00–0.18], I2 = 99 %), and 19 % prevalence of cervical lymphadenopathy (95 % CI [0.00–0.48], I2 = 100 %), while the only feature more prevalent in non-endemic areas was headache with a prevalence of 36 % (95 % CI [0.24–0.47], I2 = 96 %). In this systematic review and meta-analysis, four symptoms – headache, sore throat, cough, and cervical lymphadenopathy – were found to be the most prevalent otolaryngologic features of MPOX. Otolaryngologic manifestations of MPOX were more pronounced in prior outbreaks and in endemic areas as compared to the 2022 outbreak and non-endemic areas. These findings may aid MPOX recognition in an otolaryngology setting." @default.
• W4383873973 created "2023-07-12" @default.
• W4383873973 creator A5012285335 @default.
• W4383873973 creator A5020481968 @default.
• W4383873973 creator A5026288679 @default.
• W4383873973 creator A5045265609 @default.
• W4383873973 creator A5050273442 @default.
• W4383873973 creator A5066096821 @default.
• W4383873973 creator A5078953299 @default.
• W4383873973 creator A5082158805 @default.
• W4383873973 creator A5084934869 @default.
• W4383873973 date "2023-11-01" @default.
• W4383873973 modified "2023-09-29" @default.
• W4383873973 title "Otolaryngologic manifestations among MPOX patients: A systematic review and meta-analysis" @default.
• W4383873973 cites W1842008289 @default.
• W4383873973 cites W1972124255 @default.
• W4383873973 cites W2025856768 @default.
• W4383873973 cites W2035173164 @default.
• W4383873973 cites W2077718042 @default.
• W4383873973 cites W2166738609 @default.
• W4383873973 cites W2169536612 @default.
• W4383873973 cites W2755207975 @default.
• W4383873973 cites W2756049356 @default.
• W4383873973 cites W2765453497 @default.
• W4383873973 cites W2792764543 @default.
• W4383873973 cites W2799972028 @default.
• W4383873973 cites W2889645949 @default.
• W4383873973 cites W2955071890 @default.
• W4383873973 cites W3006150186 @default.
• W4383873973 cites W3137960965 @default.
• W4383873973 cites W4206879772 @default.
• W4383873973 cites W4214922644 @default.
• W4383873973 cites W4223444584 @default.
• W4383873973 cites W4281477179 @default.
• W4383873973 cites W4283771170 @default.
• W4383873973 cites W4285077657 @default.
• W4383873973 cites W4285085028 @default.
• W4383873973 cites W4285594459 @default.
• W4383873973 cites W4286383196 @default.
• W4383873973 cites W4289520776 @default.
• W4383873973 cites W4289918654 @default.
• W4383873973 cites W4292083143 @default.
• W4383873973 cites W4293379779 @default.
• W4383873973 cites W4293730147 @default.
• W4383873973 cites W4294151139 @default.
• W4383873973 cites W4294990761 @default.
• W4383873973 cites W4296804257 @default.
• W4383873973 cites W4297141706 @default.
• W4383873973 doi "https://doi.org/10.1016/j.amjoto.2023.103991" @default.
• W4383873973 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37487464" @default.
• W4383873973 hasPublicationYear "2023" @default.
• W4383873973 type Work @default.
• W4383873973 citedByCount "1" @default.
• W4383873973 countsByYear W43838739732023 @default.
• W4383873973 crossrefType "journal-article" @default.
• W4383873973 hasAuthorship W4383873973A5012285335 @default.
• W4383873973 hasAuthorship W4383873973A5020481968 @default.
• W4383873973 hasAuthorship W4383873973A5026288679 @default.
• W4383873973 hasAuthorship W4383873973A5045265609 @default.
• W4383873973 hasAuthorship W4383873973A5050273442 @default.
• W4383873973 hasAuthorship W4383873973A5066096821 @default.
• W4383873973 hasAuthorship W4383873973A5078953299 @default.
• W4383873973 hasAuthorship W4383873973A5082158805 @default.
• W4383873973 hasAuthorship W4383873973A5084934869 @default.
• W4383873973 hasConcept C107130276 @default.
• W4383873973 hasConcept C116675565 @default.
• W4383873973 hasConcept C126322002 @default.
• W4383873973 hasConcept C141071460 @default.
• W4383873973 hasConcept C142724271 @default.
• W4383873973 hasConcept C16005928 @default.
• W4383873973 hasConcept C17744445 @default.
• W4383873973 hasConcept C187212893 @default.
• W4383873973 hasConcept C199539241 @default.
• W4383873973 hasConcept C23131810 @default.
• W4383873973 hasConcept C2776478404 @default.
• W4383873973 hasConcept C2777870961 @default.
• W4383873973 hasConcept C2779473830 @default.
• W4383873973 hasConcept C71924100 @default.
• W4383873973 hasConcept C95190672 @default.
• W4383873973 hasConceptScore W4383873973C107130276 @default.
• W4383873973 hasConceptScore W4383873973C116675565 @default.
• W4383873973 hasConceptScore W4383873973C126322002 @default.
• W4383873973 hasConceptScore W4383873973C141071460 @default.
• W4383873973 hasConceptScore W4383873973C142724271 @default.
• W4383873973 hasConceptScore W4383873973C16005928 @default.
• W4383873973 hasConceptScore W4383873973C17744445 @default.
• W4383873973 hasConceptScore W4383873973C187212893 @default.
• W4383873973 hasConceptScore W4383873973C199539241 @default.
• W4383873973 hasConceptScore W4383873973C23131810 @default.
• W4383873973 hasConceptScore W4383873973C2776478404 @default.
• W4383873973 hasConceptScore W4383873973C2777870961 @default.
• W4383873973 hasConceptScore W4383873973C2779473830 @default.
• W4383873973 hasConceptScore W4383873973C71924100 @default.
• W4383873973 hasConceptScore W4383873973C95190672 @default.
• W4383873973 hasIssue "6" @default.
• W4383873973 hasLocation W43838739731 @default.
• W4383873973 hasLocation W43838739732 @default.
• W4383873973 hasOpenAccess W4383873973 @default.

• next